Page results
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
-
This page has been written by the Physiotherapy Services at the Royal London Hospital for Integrated Medicine. It is for patients who have been referred to the clinic.
-
The Ataxia Centre brings together a team of specialists, with expertise in the diagnosis, management and research of all forms of ataxia.
-
We offer comprehensive assessment, diagnostic services and investigation for all forms of the disease including neuropsychology, neurophysiology, imaging, genetic testing and tissue diagnosis.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
-
The department specialises in the assessment and management of complex neuropsychiatric conditions occurring in the context of neurological disease.
-
Skeletal uscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
The maternity team at UCLH will listen to your hopes and concerns and can suggest helpful and practical ideas to help you.
-
The service offers psychotherapeutic intervention for women receiving ante-natal and post-natal care at UCLH, their partners, and their children in the event of perinatal loss.
-
The molecular genetics laboratory at UCLH is a national centre for the genetic diagnosis of haemoglobin disorders, including prenatal diagnosis.
File results
-
FOI/2023/0635 - Redundancy consultation
-
FOI/2023/0623 - BMA rate card rates
-
FOI/2023/0617 - Neonatal unit CCTV
-
FOI/2023/0615 - Wayfinding strategy
-
FOI/2023/0613 - Treatment for Melanoma
-
FOI/2023/0578 - Spinal Muscular Atrophy (SMA) patients
-
FOI/2023/0581 - Treatment of Haemophilia
-
FOI/2023/0579 - Procurement for specialist seating for patients
-
FOI/2023/0586 - Children treated for E-scooter injuries
-
FOI/2023/0569 - Treatment for Ruxolitinib